2009 Signature Genomic Laboratories Travel Award winner... ( Kathy M. Chun PhD FACMG was honored ...)

2009 Signature Genomic Laboratories Travel Award winner announced

Date:3/31/2009

Kathy M. Chun, PhD, FACMG was honored as the 2009 recipient of the Signature Genomic Laboratories Travel Award at the American College of Medical Genetics (ACMG) 2009 Annual Clinical Genetics Meeting in Tampa, Florida. Dr. Chun is Director, Cytogenetics and Molecular Genetics at the North York General Hospital in Toronto, Canada. Dr. Chun received her PhD from the University of Toronto in Biochemistry.

A new award in 2008, the Signature Genomics Travel Award is given to a selected student, trainee or junior faculty ACMG member whose abstract submission was chosen as a platform presentation during the ACMG Annual Clinical Genetics Meeting. The ACMG program committee selects the Travel Award recipient based on scientific merit. In recognition of the selected presentation, Signature Genomics covers the travel costs for the recipient to the ACMG meeting.

"The American College of Medical Genetics Foundation is grateful to Signature Genomics for their generous support of up-and-coming medical genetic researchers through the Signature Genomics Travel Award," said R. Rodney Howell, MD, FACMG, president of the ACMGF.

"Signature supports the recognition of outstanding young researchers in the field of medical genetics, "said Lisa G. Shaffer, PhD, president and CEO of Signature Genomics. "We are proud to be sponsoring this award."

'/>"/>

Contact: Kathy Ridgely Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

0

GOOD

Post Your Comments:

(Date:2/24/2015)... Feb. 24, 2015 This report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle East ... estimates and forecasts are provided for the period 2013 through ... markets. Market data and analytics are derived from primary and ...

(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...

(Date:2/10/2015)... 10, 2015 Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...

[1] World Iris Biometrics Industry [0] Cepheid to Webcast Upcoming Financial Presentations [1] Alere Inc. Announces Fourth Quarter 2014 Results

... MA.April 25th, 2012Aspera, Inc., creators of next-generation software ... speed, and BGI, the world,s largest genomics research ... have partnered to integrate and deploy the Aspera ... technology with "EasyGenomicsTM", BGI,s latest cloud-based Software as ...

... in state in 1970s; Zoo has monitored for beetle since ... Beetle Conservation; the U.S. Fish & Wildlife Service; the Missouri ... to 600 Zoo-bred American burying beetles for the first ... across the 4,040-acre Wah, Kon-Tah Prairie in Southwest Missouri. ...

... reported to increase risk of developing hepatocellular carcinomas (HCC), independent ... of Hepatology , a journal of the American Association ... 70-fold elevated risk of HCC in those with liver cancer ... hepatitis C (HCV). Liver cancer ranks sixth in ...

Cached Biology News:BGI and Aspera collaborate on high-speed data exchange to advance genome research 2 First-ever release of endangered burying beetles in Missouri 2 First-ever release of endangered burying beetles in Missouri 3 First-ever release of endangered burying beetles in Missouri 4 Family history of liver cancer increases risk of developing the disease 2

BGI and Aspera collaborate on high-speed data exchange to advance genome research First-ever release of endangered burying beetles in Missouri Family history of liver cancer increases risk of developing the disease

(Date:3/2/2015)... March 2, 2015 Pfenex Inc. (NYSE MKT: ... development of biosimilar therapeutics, today announced that it ... Healthcare Conference in Miami, FL at the Loews Miami Beach ... officer of Pfenex, will provide an overview of ... 12th at 9:00 am ET. A live audio webcast and ...

(Date:3/2/2015)... 2015 Editor Note: For more ... Moments ago, Analysts Review released new research updates ... (NASDAQ: SSH ), Synergetics USA ... ELOS ), Spectranetics (NASDAQ: SPNC ), and ... single unified platform for investors, to hear about what matters ...

(Date:3/2/2015)... SANTA BARBARA, Calif. , March 2, 2015 ... a biotechnology company developing therapies for autoimmune and ... Trademark Office (USPTO) has issued an important new ... immune system function through the targeting of CLIP. ... the targeted peptide technology underlying VG Life Sciences, ...

(Date:3/2/2015)... Global Stem Cells Group.com ... Shenzhen HANK Bioengineering Co., Ltd. and its Chinese-American ... establish a stem cells training course in the ... 2015. , Shenzhen HANK is a biotechnology company ... microbiologist and virologist, to integrate research, development, production, ...

Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2 Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3 Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4 VG Life Sciences Granted Key Composition Of Matter Patent 2 VG Life Sciences Granted Key Composition Of Matter Patent 3 Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2 Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3

[0] Pfenex to Present at the 2015 Barclays Global Healthcare Conference [0] Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec [0] VG Life Sciences Granted Key Composition Of Matter Patent [0] Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China

... Launch Interactive, Case-Based Website on Cardiovascular Disease for ... Whether it,s a common heart condition or a ... similar patient. That,s why the Society for Cardiovascular ... Inc. (EVF), an IC Sciences Company, today unveiled ...

... iZumi Bio, Inc., a biotechnology company focused on ... technology with the mission of creating new therapeutics ... cells, today announced the appointments of Berta Strulovici, ... Pathak, Ph.D., as vice president of Business Development. ...

... announced successful,completion of the single-day oral dosing part ... patients with its new anti-cancer drug AXL1717,an,insulin-like growth ... the closely related insulin receptor. The study is ... The results showed that a single-day,dosing of AXL1717 ...

Cached Biology Technology:New Website Connects Physicians to Solve Challenging Cases and Share Experiences 2 New Website Connects Physicians to Solve Challenging Cases and Share Experiences 3 New Website Connects Physicians to Solve Challenging Cases and Share Experiences 4 iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 2 iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 3 Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar AB 2

New Website Connects Physicians to Solve Challenging Cases and Share Experiences iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar AB

St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles...

Mouse Anti-Gemin2...

5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...

Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...

Biology Products:

Mouse Anti-St. Louis encephalitis Monoclonal Antibody, Unconjugated, Clone 6B5A-2 from ABR-Affinity BioReagents Mouse Anti-Gemin 2 Monoclonal Antibody, Unconjugated, Clone 2E17 from ImmuQuest Ltd.5-bromo-2'-deoxyuridine (BrdU) from Molecular Probes (Invitrogen)Goat Anti-Rat CINC-2 alpha / beta Polyclonal Antibody, Unconjugated from R&D Systems